Poster Presentation at the 2026 Crohn's & Colitis Congress® Showcases Use of Causal Machine Learning and IBD Plexus® to Optimize Trial Execution BOSTON, Jan. 22, 2026 /PRNewswire/ -- PhaseV, a leader in AI/ML for clinical development, is today presenting new study results demonstrating...
Hence then, the article about phasev demonstrates how ai driven site selection and real time analytics reduce recruitment uncertainty and accelerate ibd clinical trials was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( PhaseV Demonstrates How AI-Driven Site Selection and Real-Time Analytics Reduce Recruitment Uncertainty and Accelerate IBD Clinical Trials )
Also on site :
- ‘Free Bert’ Review: Bert Kreischer Strips Away the Shirtless Party Boy Persona, but Also the Laughs, in New Netflix Comedy
- South Africa pushes for renewable energy investment
- 2010s Country Singer Announces New Dates for Live In Concert